Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Sanofi sales slide on patent cliff woes

August 1, 2013 Sales and Marketing Aprovel, Plavix, Q2, Sanofi

Sanofi has been hit by generic erosion for key drugs in the second quarter, but the firm is confident it …
News

Internis hires Sandoz’ Paul Tredwell as COO

August 1, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Internis, Tredwell

Developer and supplier of bone disorder treatments Internis Pharmaceuticals has appointed Paul Tredwell as chief operating officer. Tredwell will report …
Appointment

Lipitor competition holds Pfizer back

July 31, 2013 Sales and Marketing Lipitor, Pfizer, Prevnar, Q2

Pfizer’s revenues in the second quarter of 2013 fell 7% year-on-year, in part due to the loss of patent in …
News

Merck sees sales dip

July 31, 2013 Sales and Marketing Merck, Q2, Singulair, sales

A catastrophic decline in sales of asthma medicine Singulair is among the key reasons why Merck’s pharma revenue fell 12% …
News

UK life sciences gains £93 million backing

July 31, 2013 Research and Development, Sales and Marketing BIA, DMD, life sciences

The UK life sciences sector has been given a new £93.2 million package of support by the government to help …
News

MHRA appoints three directors to its Board

July 31, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, MHRA

The Department of Health has announced that three new non-executive directors are joining the Medicines and Healthcare Products Regulatory Agency. …
Appointment

Adderall hits Shire sales

July 30, 2013 Sales and Marketing Adderall, Shire, Vyvanse, ldx

Falling sales of Adderall XR have hit Shire in the second quarter of the year, with the ADHD drug dropping …
News

January deadline for Pfizer restructure

July 30, 2013 Research and Development, Sales and Marketing Pfizer, patent, restructure

Pfizer is to restructure operations from January 2014 in a bid to make its business more responsive to patient and …
News

Nearly all UK men survive testicular cancer

July 30, 2013 Research and Development, Sales and Marketing

Survival for testicular cancer has risen by almost 30% in the last 40 years, with nearly all men now beating …
News

Perrigo pays $8.6 billion for Elan

July 30, 2013 Research and Development, Sales and Marketing Elan, Perrigo, Tysabri

Generics firm Perrigo has snapped up Ireland-based Elan in a multi-billion dollar deal, ending a bitter takeover battle that has …
News

Aesica appoints Chris Gowland to the Board

July 30, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Aesica, Chris Gowland

Contract development and manufacturing organisation Aesica has appointed Chris Gowland to the newly formed position of chief operating officer. As …
Appointment

Patients and profits – time for new priorities

July 29, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, McConaghie, andrew, pharma, profits

Pharmaceutical journalists don’t retire, they just go off patent. Well, I’m not retiring as such, but after ten years as …
Feature

EMA: no cancer risk from GLP-1s

July 29, 2013 Research and Development, Sales and Marketing Cancer, EMA, GLP-1s

One of the European Medicines Agency’s key advisory groups has decided that concerns over an increased cancer risk with some …
News

AZ and BMS go for second Forxiga submission

July 29, 2013 Sales and Marketing AZ, BMS, FDA, Forxiga

AstraZeneca and partner Bristol-Myers Squibb have resubmitted their diabetes drug Forxiga to the FDA 18 months after it was rejected …
News

Boehringer nears European approval for first cancer drug

July 29, 2013 Sales and Marketing Boehringer, Cancer, FDA, afatinib

Boehringer’s first cancer drug is just months away from being approved in Europe after a committee for the EMA gave …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026